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httpResults with an algorithmic approach to hybrid
repair of the aortic arch
Nicholas D. Andersen, MD,a Judson B. Williams, MD, MHS,a Jennifer M. Hanna, MD, MBA,a
Asad A. Shah, MD,a Richard L. McCann, MD,b and G. Chad Hughes, MD,a Durham, NC
Objective: Hybrid repair of the transverse aortic arch may allow for aortic arch repair with reduced morbidity in patients
who are suboptimal candidates for conventional open surgery. We present our results with an algorithmic approach to
hybrid arch repair, based on the extent of aortic disease and patient comorbidities.
Methods: Between August 2005 and January 2012, 87 patients underwent hybrid arch repair by three principal proce-
dures: zone 1 endograft coverage with extra-anatomic left carotid revascularization (zone 1; n [ 19), zone 0 endograft
coverage with aortic arch debranching (zone 0; n [ 48), or total arch replacement with staged stented elephant trunk
completion (stented elephant trunk; n [ 20).
Results: The mean patient age was 64 years, and the mean expected in-hospital mortality rate was 16.3% as calculated by
the EuroSCORE II. Of operations, 22% (n [ 19) were nonelective. Sternotomy, cardiopulmonary bypass, and deep
hypothermic circulatory arrest were required in 78% (n[ 68), 45% (n[ 39), and 31% (n[ 27) of patients to allow for
total arch replacement, arch debranching, or other concomitant cardiac procedures, including ascending with or without
hemiarch replacement in 17% (n [ 8) of patients undergoing zone 0 repair. All stented elephant trunk procedures (n [
20) and 19% (n[ 9) of zone 0 procedures were staged, with 41% (n [ 12) of patients undergoing staged repair during
a single hospitalization. The 30-day/in-hospital rates of stroke and permanent paraplegia or paraparesis were 4.6% (n[
4) and 1.2% (n[ 1). Of 27 patients with native ascending aorta zone 0 proximal landing zone, three (11.1%) experienced
retrograde type A dissection after endograft placement. The overall in-hospital mortality rate was 5.7% (n[ 5); however,
30-day/in-hospital mortality increased to 14.9% (n [ 13) owing to eight 30-day out-of-hospital deaths. Native
ascending aorta zone 0 endograft placement was found to be the only univariate predictor of 30-day in-hospital mortality
(odds ratio, 4.63; 95% conﬁdence interval, 1.35-15.89; P[ .02). Over a mean follow-up period of 28.5 ± 22.2 months,
13% (n [ 11) of patients required reintervention for type 1A (n [ 4), type 2 (n [ 6), or type 3 (n [ 1) endoleak.
Kaplan-Meier estimates of survival at 1 year, 3 years, and 5 years were 73%, 60%, and 51%.
Conclusions:Hybrid aortic arch repair can be tailored to patient anatomy and comorbid status to allow complete repair of
aortic pathology, frequently in a single stage, with acceptable outcomes. However, endograft placement in the native
ascending aorta is associated with high rates of retrograde type A dissection and 30-day/in-hospital mortality and should
be approached with caution. (J Vasc Surg 2013;57:655-67.)Conventional open repair of thoracic aortic pathology
involving the transverse aortic arch is associated with signif-
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://dx.doi.org/10.1016/j.jvs.2012.09.039candidates for conventional open operation. A strategy
that incorporates thoracic endovascular aortic repair
(TEVAR) into “hybrid” open/endovascular aortic arch
procedures may allow for aortic arch repair with reduced
morbidity and allow for repair in patients who are subop-
timal candidates for open surgery. Speciﬁcally, hybrid
arch procedures can be used for multisegment aortic arch
repair while avoiding morbidity associated with thora-
cotomy or thoracosternotomy incisions, cardiopulmonary
bypass (CPB), hypothermic circulatory arrest, and inter-
stage attrition in patients requiring staged open repair.
Despite the potential advantages of less invasive hybrid
arch procedures, outcomes after hybrid arch repair remain
unclear. Limitations of existing data include small patient
numbers, diverse operations performed for varying indica-
tions, and imprecise terminology.1-20 In this article, we
review our results with hybrid arch repair using an algo-
rithmic approach to patient and operative selection and
standardized operative techniques.
METHODS
Patient population and data collection. This study
was approved by the institutional review board of Duke655
Fig 1. Algorithm for hybrid aortic arch repair. *These criteria are relative factors in the decision-making process, not
absolute indications or contraindications. Ideally, the decision for conventional vs hybrid repair should be made by
a surgical team with expertise in both techniques. Institutional results with each approach should further inﬂuence the
decision-making process.
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waived. The Duke Thoracic Aortic Surgery Database is
a prospectively maintained electronic clinical registry of
all patients who have undergone thoracic aortic surgery
at Duke University Medical Center (Durham, NC) since
2005.21,22 A query of the database identiﬁed 387 consec-
utive TEVAR operations performed between March 2005
and January 2012; 87 operations (22%) were hybrid arch
repairs, and these form the basis of this report. General
criteria regarding patient selection for hybrid arch repair are
presented in Fig 1. Patients with advanced age, extensive
comorbidities, or high-risk anatomic features are prefer-
entially selected for less invasive hybrid repairs at our
institution.
Aortic arch landing zones were deﬁned using the Ishi-
maru classiﬁcation.23 Hybrid arch repairs were deﬁned
as repairs involving endograft coverage of the innominate
artery or left common carotid artery (LCCA) or both
(zone 0 or zone 1 proximal landing zone) or endovascular
completion after total arch replacement (stented elephant
trunk). Operations involving coverage of the left subcla-
vian artery (LSCA) only (zone 2 proximal landing zone)
were excluded. Comorbid conditions and postoperative
complications were deﬁned using Society of Thoracic
Surgeons deﬁnitions (www.sts.org). European System for
Cardiac Operative Risk Evaluation (EuroSCORE) II
scores were calculated (http://euroscore.org/calc.html).24
Aortic diameter measurements were obtained using the
centerline method with a TeraRecon Aquarius iNtuition
workstation (TeraRecon Inc., San Mateo, Calif).Indications for surgery, techniques of device delivery
and deployment, and postoperative surveillance have been
described previously.3-5 Indications for operation were
classiﬁed as degenerative aneurysm (fusiform, saccular, or
penetrating atherosclerotic ulcers), acute dissection, or
chronic dissection. All commercially available endografts
available during the study period were used and included
the Gore TAG and C-TAG (W. L. Gore & Assoc, Flagstaff,
Ariz), Medtronic Talent (Medtronic, Santa Rosa, Calif),
and Zenith TX2 (Cook Inc, Bloomington, Ind) devices.
Primary technical success was deﬁned according to Society
of Vascular Surgery reporting standards.25
Statistical analysis. Continuous and categorical vari-
ables were compared between groups using the Kruskal-
Wallis test and c2 test. Survival was estimated using the
Kaplan-Meier method. For patients who underwent
staged repair, the date of the completion procedure was
used to calculate survival. Survival was compared between
groups using the log-rank test. Calculations were per-
formed using STATA 11.1 (StataCorp, College Station,
Tex).
Operative techniques
Patient preparation and monitoring. Preoperative
coronary angiography was performed for previously estab-
lished indications.26 All cases were performed with
continuous transesophageal echocardiography monitoring.
Intraoperative neurophysiologic monitoring of spinal cord
somatosensory and motor-evoked potentials was per-
formed for elective cases and when available for nonelective
Fig 2. Zone 1 hybrid arch repair. In the case depicted, the carotid-
carotid bypass graft was extended to revascularize the left subcla-
vian artery, and the proximal left subclavian artery was occluded
with an AMPLATZER vascular plug (St. Jude Medical Inc, St.
Paul, Minn) to prevent type II endoleak.
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raphy (EEG) neurocerebral monitoring was used in all
elective zone 0 hybrid arch repairs (37/48; 77%) to assess
for cerebral ischemia during arch debranching.3,5 Adjunc-
tive intravascular ultrasound scanning was used in all
dissection cases as previously described.28 Routine inspec-
tion of the ascending aorta for retrograde type A dissection
was performed at case completion by transesophageal
echocardiography and intravascular ultrasound scanning
when used.29
Zone 1 hybrid arch repair. Zone 1 hybrid arch repair
was employed for patients with distal arch pathology but
with $2 cm of proximal landing zone distal to the innom-
inate artery.3,5 First, an 8-mm polytetraﬂuoroethylene
carotid-carotid bypass was performed via an anterior sub-
platysmal plane. The graft was extended to revascularize
the LSCA, when indicated.30 The proximal LCCA was
ligated to prevent type II endoleak. The proximal LSCA
was similarly ligated or occluded to prevent endoleak, when
necessary. The endograft was delivered via retrograde
access and deployed with a zone 1 proximal landing site
(Fig 2).
Zone 0 hybrid arch repair. Zone 0 hybrid arch repair
was used for patients with mid–transverse arch pathology
but with >2 cm of proximal landing zone in the ascending
aorta. Ascending aorta–based arch debranching was per-
formed using a custom-designed Dacron hybrid ante-
grade arch graft (Vascutek USA, Ann Arbor, Mich) to
debranch the innominate artery and LCCA and allow for
antegrade endograft delivery.3-5 First, a left carotid–
subclavian bypass was performed in the neck, followed by
median sternotomy. The ascending aorta debranching
graft inﬂow anastomosis was performed without CPB
(pump on standby) using a partial occlusion clamp tech-
nique. The LCCA was debranched ﬁrst, with full left
cerebral blood ﬂow supplied by retrograde ﬂow in the left
carotid–subclavian bypass (Fig 3, A). The innominate
artery was then debranched following a 3-minute test
clamp to assess for EEG ischemic changes as previously
described.3-5 The endograft was delivered antegrade or
retrograde across the arch with a zone 0 proximal landing
site (Fig 3, B). The decision to deliver the endograft
antegrade or retrograde was determined by the device used
because only the Gore devices are capable of antegrade
delivery. In patients with prior ascending aorta replace-
ment, the artiﬁcial Dacron ascending aorta served as the
inﬂow site for the arch debranching graft and proximal
landing zone.
For patients with native ascending aorta deemed
unsuitable for proximal landing zone, generally owing to
a diameter $40 mm, ascending aorta with or without
hemiarch replacement was ﬁrst performed together with
arch debranching on CPB, as previously described,21
with the arch debranching graft anastomosed to the newly
constructed Dacron ascending aorta (Fig 4, A). For
patients requiring hemiarch replacement, deep hypo-
thermic circulatory arrest (DHCA) with antegrade cere-
bral perfusion via right axillary cannulation was usedduring hemiarch replacement and arch debranching.21
The distal arch and descending aortic pathologies were
deﬁnitively treated by endografting with Dacron zone
0 proximal landing zone, typically during a second-stage
procedure (Fig 4, B). We favor staged repair in this
scenario given the competing postoperative management
strategies with regard to blood pressure following open
proximal vs endovascular distal aortic repair. In the former
scenario, the patient is frequently coagulopathic after CPB
with or without DHCA, and lower mean arterial pressures
are preferred in the early postoperative period to reduce
bleeding, whereas in the latter scenario, where bleeding
is generally not an issue, higher mean arterial pressures
are favored for spinal cord protection. Similar to our ﬁnd-
ings with hybrid thoracoabdominal repair, staged repair
reduces the nephrotoxic insult of prolonged surgery fol-
lowed by contrast agent administration, reduces blood
loss by limiting the period of heparinization, and allows
for patient recovery and medical optimization before the
second-stage procedure.31 The only exception to this
rule is in the setting of rupture (one patient in this series),
where the proximal aortic replacement using CPB and the
endovascular portion of the repair must be done as a single
stage.
Total arch replacement with staged stented elephant
trunk completion. Total arch replacement with staged
stented elephant trunk completion was used for patients
Fig 3. Native zone 0 hybrid arch repair. A, Initial construction of a left carotid-subclavian bypass allows uninterrupted
left cerebral blood ﬂow during left common carotid artery debranching. B, Following arch debranching, the endograft
is deployed with native ascending aorta proximal landing zone. The arch debranching graft used incorporates an
integral limb just above the inﬂow anastomosis to allow for antegrade endograft delivery without the need for femoral
exposure. This limb is oversewn after completion of the procedure.
Fig 4. Dacron zone 0 hybrid arch repair with ascending aorta and hemiarch replacement. A, In the ﬁrst-stage
procedure, ascending aorta and hemiarch replacement are performed followed by arch debranching from the newly
constructed Dacron ascending aorta. B, Endografting is performed during a second procedure with the Dacron
ascending aorta serving as proximal landing zone. In the case depicted, a left carotid-subclavian bypass was performed
during the second-stage procedure to revascularize the left subclavian artery, and the proximal left subclavian artery was
occluded with a vascular plug to prevent type II endoleak.
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(“mega-aorta”) not amenable to proximal landing zone
reconstruction. The ﬁrst stage involved total arch replace-
ment with a collared elephant trunk graft (Vascutek) withuse of CPB and DHCA, using a modiﬁed Mt. Sinai tech-
nique as previously described (Fig 5, A).5 The graft
employed incorporates radiographic markers that facilitate
second-stage repair. Four large hemoclips are placed
Fig 5. Total arch replacement with staged stented elephant trunk completion. A, First-stage procedure involves total
arch replacement using a modiﬁed Mt. Sinai technique. B, Second-stage procedure involves endovascular completion
with the elephant trunk graft serving as proximal landing zone. Note the radiographic markers, hemoclips, and pacing
wires on the elephant trunk graft.3
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trunk graft to assist with identiﬁcation under ﬂuoroscopy.
Pacing wires (#0) are also secured to the distal end of the
elephant trunk and allowed to trail distally a few centi-
meters into the descending thoracic aorta. The second
stage involved completion endografting with at least 10
cm of proximal landing zone in the Dacron elephant trunk
(Fig 5, B).3,5 At the time of endograft deployment, either
of the wires is snared to provide countertraction and to
prevent graft intussusception as the endograft is advanced
retrograde into the Dacron elephant trunk. Staged repair is
performed in all cases for the same reasons as described
previously.
RESULTS
Operative details and 30-day/in-hospital outcomes.
Patient demographics are shown in Table I, operative
characteristics are shown in Table II, arch vessel bypass grafts
are shown in Table III, and 30-day/in-hospital outcomes
are shown in Table IV.
Zone 1 hybrid arch repair. Zone 1 hybrid arch repair
was performed in 19 patients with an average age of 67
years. The expected in-hospital mortality rate was 17.8%
as calculated by the EuroSCORE II.24 Six (32%) patients
underwent nonelective operation because of symptomatic
aneurysm (n ¼ 4) or complicated acute type B dissection
(n ¼ 2). One patient required median sternotomy and CPB
to allow for concomitant coronary artery bypass grafting,
and this patient underwent aorta-LCCA bypass for LCCA
revascularization. A second patient underwent LCCArevascularization via right subclavian artery (RSCA)–LCCA
bypass owing to an enlarged right-sided thyroid goiter that
precluded right common carotid artery exposure. The
LSCA was revascularized in 53% (n ¼ 10) of patients for
previously described indications.30
One (5.3%) patient experienced delayed-onset perma-
nent paraplegia on postoperative day 1 after urgent repair
of a complicated acute type B dissection involving distal
endograft coverage to the celiac axis. In this patient, the
LSCA was revascularized at the time of operation because
of a patent left internal mammary artery coronary bypass
graft. One (5.3%) patient died intraoperatively of myocar-
dial infarction following an endograft-induced inferior
vena cava injury. The primary technical success rate was
95% (18/19) as a result of the intraoperative death.
Zone 0 hybrid arch repair. Zone 0 hybrid arch repair
was performed in 48 patients with an average age of 65
years. The expected in-hospital mortality rate was 17.3%
as calculated by the EuroSCORE II.24 Nonelective oper-
ation was performed in 23% (n ¼ 11) of patients because of
contained ruptured aneurysm (n ¼ 2), symptomatic
aneurysm (n ¼ 2), coronary artery disease with recent
myocardial infarction and concomitant arch aneurysm (n ¼
2), mycotic aneurysm with aorta–innominate vein ﬁstula
(n ¼ 1), aberrant RSCA aneurysm with vascular-
esophageal ﬁstula (n ¼ 1), acute type A dissection (n ¼
1), or type IA endoleak following zone 2 TEVAR.
A median sternotomy for arch debranching was
required in 98% (n¼47) of patients. Arch debranching
was completed without sternotomy in one patient who
Table I. Demographics
Variable Total (N ¼ 87) Zone 1 (n ¼ 19) Zone 0 (n ¼ 48) Total arch þ SET (n ¼ 20) P
Patient characteristics
Age, years 64 6 13 67 6 14 65 6 12 59 6 12 .07
Male gender 45 (52%) 8 (42%) 26 (54%) 11 (55%) .64
White race 60 (69%) 14 (74%) 34 (71%) 12 (60%) .60
Body mass index 26.3 6 5.7 25.6 6 4.5 26.7 6 6.3 26.1 6 5.3 .76
Patient comorbidities
Hypertension 79 (91%) 15 (79%) 44 (92%) 20 (100%) .07
Hyperlipidemia 54 (62%) 11 (58%) 33 (69%) 10 (50%) .32
History of tobacco use 60 (69%) 12 (63%) 33 (69%) 15 (75%) .73
Diabetes 9 (10%) 4 (21%) 4 (8%) 1 (5%) .21
Coronary artery disease 30 (34%) 7 (37%) 18 (38%) 5 (25%) .60
History of stroke 18 (21%) 4 (21%) 9 (19%) 5 (25%) .84
COPD 33 (38%) 4 (21%) 18 (38%) 11 (55%) .09
Baseline creatinine >1.5 mg/dL 24 (28%) 3 (16%) 16 (33%) 5 (25%) .34
Peripheral vascular disease 24 (28%) 6 (32%) 15 (31%) 3 (15%) .36
Connective tissue disease 6 (7%) 0 3 (6%) 3 (15%) .18
Prior aortic surgery 42 (48%) 9 (47%) 23 (48%) 10 (50%) .98
EuroSCORE II (%)24 16.3 6 11.0 17.8 6 11.6 17.3 6 11.8 12.5 6 7.8 .27
COPD, Chronic obstructive pulmonary disease; SET, stented elephant trunk.
Values expressed as mean 6 standard deviation or number (percent).
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another institution including ascending aorta-RSCA bypass
graft for concomitant innominate artery aneurysm. In this
patient, arch vessel revascularization was accomplished via
RSCA-right common carotid artery-LCCA bypass.
We used CPB in 38% (n ¼ 18) of patients. In 16
patients, CPB was required for concomitant cardiac opera-
tions, and CPB was required for repair of a pulmonary
artery injury in the redo sternotomy setting in one patient.
The remaining patient was placed on CPB for cooling
because of persistent EEG ischemic changes with innomi-
nate artery test clamping. The EEG changes with test
clamping resolved after cooling to 27C, at which time
innominate artery debranching was performed. Despite
these maneuvers, the patient experienced an ischemic right
hemispheric stroke. In 15% (n ¼ 7) of patients, DHCA was
required to accommodate hemiarch replacement. Staged
open/endovascular repair was performed in 19% (n ¼ 9)
of patients, of whom 44% (n ¼ 4) underwent completion
of both stages during a single hospitalization.
In 56% (n ¼ 27) of patients, arch debranching and
zone 0 endograft placement with arch debranching inﬂow
and proximal landing zone in native ascending aorta was
performed, whereas the remaining 44% (n ¼ 21) under-
went arch debranching and zone 0 endograft placement
using artiﬁcial Dacron ascending aorta owing to prior
ascending aorta replacement (n ¼ 13) or concomitant
ascending aorta replacement at the time of arch debranch-
ing (n ¼ 8). The LSCA was revascularized in 46% (n ¼ 22)
of patients as part of the native zone 0 arch debranching
procedure or for previously described indications.30
Stroke occurred in 4.2% (n ¼ 2) of zone 0 patients.
The ﬁrst patient was the aforementioned patient with
EEG changes during innominate artery test clamping.
The second patient experienced a thromboembolic stroke
on postoperative day 7 after uneventful hospital discharge.Retrograde type A dissection occurred in three zone
0 patients for an overall rate of 6.3% but a true rate of
11.1% (3/27) when including only patients with native
ascending aorta who were at risk for this complication.
The ﬁrst patient died intraoperatively from right ventric-
ular failure after emergent open repair. The second patient
died suddenly on postoperative day 3 and was diagnosed
with retrograde type A dissection at autopsy. The third
patient underwent successful open repair after intraopera-
tive identiﬁcation of the dissection by transesophageal
echocardiography following completion of the TEVAR
procedure.
Of patients, 8.3% (n¼ 4) died before hospital discharge.
The causes of death were retrograde type A dissection
(n ¼ 2), atheroembolic syndrome (n ¼ 1), and sepsis
(n ¼ 1). Six additional patients died after hospital
discharge but within 30 days of surgery, yielding a 30-
day/in-hospital mortality rate of 20.8%. The causes of
death were known for three of the six patients who
died out of hospital and included respiratory failure after
long-term care facility transfer on mechanical ventilation
(n ¼ 2) and upper gastrointestinal bleeding (n ¼ 1).
The remaining three patients died of unknown causes
6, 7, and 14 days after uneventful discharge to home.
The 30-day/in-hospital mortality was 29.6% (8/27) for
patients with native zone 0 proximal landing zones
compared with 9.5% (2/21) for patients with Dacron
zone 0 proximal landing zones (P ¼ .15). The primary
technical success rate was 96% (46/48) as a result of
two patient deaths within 24 hours of operation (retro-
grade type A dissection and atheroembolic syndrome).
Total arch replacement with staged stented
elephant trunk completion. Total arch replacement with
staged stented elephant trunk completion was performed in
20 patients with an average age of 59 years. The expected
in-hospital mortality rate was 12.5% as calculated by the
Table II. Operative characteristics
Variable Total (N ¼ 87) Zone 1 (n ¼ 19) Zone 0 (n ¼ 48) Total arch þ SET (n ¼ 20) P
Indication .09
Aneurysm 54 (62%) 14 (74%) 30 (63%) 10 (50%)
Acute dissection 3 (3%) 2 (11%) 1 (2%) 0
Chronic dissection 30 (34%) 3 (16%) 17 (35%) 10 (50%)
Maximum aortic diameter, cm 6.5 6 1.5 6.0 6 1.9 6.3 6 1.4 7.2 6 1.2 .02
Case status .49
Elective 68 (78%) 13 (68%) 37 (77%) 18 (90%)
Urgent 14 (16%) 5 (26%) 8 (17%) 1 (5%)
Emergent 5 (6%) 1 (5%) 3 (6%) 1 (5%)
Concomitant procedures 29 (33%) 1 (5%) 16 (33%) 12 (60%) .001
Coronary artery bypass grafting 12 (14%) 1 (5%) 7 (15%) 4 (20%)
AVR 5 (6%) 2 (4%) 3 (15%)
Aortic valve repair 3 (3%) 1 (2%) 2 (10%)
Sinus of Valsalva aneurysm repair 1 (1%) 1 (5%)
Root replacement 2 (2%) 2 (10%)
Valve-sparing root replacement 3 (3%) 1 (2%) 2 (10%)
Ascending aorta replacement 1 (1%) 1 (2%)
Ascending þ hemiarch 5 (6%) 5 (10%)
AVR þ ascending þ hemiarch 1 (1%) 1 (2%)
Root þ hemiarch 1 (1%) 1 (2%)
Hybrid TAAA 3 (3%) 1 (2%) 2 (10%)
Open procedure
Sternotomy 68 (78%) 1 (5%) 47 (98%) 20 (100%) <.0001
Redo sternotomy 25 (29%) 0 17 (35%) 9 (40%) .007
Use of CPB 39 (45%) 1 (5%) 18 (38%) 20 (100%) <.0001
Cross-clamp time, minutes 120 6 58 46 87 6 53 151 6 45 .003
CPB time, minutes 214 6 65 122 178 6 69 252 6 29 .0001
Use of DHCA 27 (31%) 0 7 (15%) 20 (100%) <.0001
Cerebral DHCA time, minutes 7.3 6 5.2 NA 4.9 6 5.0 8.3 6 5.1 .07
Antegrade CP time, minutes 21.6 6 7.5 NA 13.7 6 4.2 24.5 6 6.3 .0009
Systemic DHCA time, minutes 49.0 6 23.3 NA 18.6 6 6.5 60.2 6 15.7 .0002
Endovascular procedure
Staged procedure 29 (33%) 0 9 (19%) 20 (100%) <.0001
Staged same hospitalization 12 (41%) NA 4 (44%) 8 (40%) .82
Duration between stages, days 68 [8, 151] NA 63 [9, 154] 72 [8, 143] .69
Number of stents implanted 2.1 6 1.0 1.6 6 0.7 2.1 6 1.0 2.6 6 1.1 .01
Antegrade stent deployment 32 (37%) 0 32 (67%) 0 <.0001
Native aorta proximal landing zone 46 (53%) 19 (100%) 27 (56%) 0 <.0001
Native zone 0 proximal landing zone 27 (31%) 0 27 (56%) 0 <.0001
Native ascending aorta $4.0 cm 12 (14%) 3 (16%) 9 (19%) 0 .12
Native aorta distal landing zone 79 (91%) 18 (95%) 45 (94%) 16 (80%) .16
Proximal device .57
TAG / C-TAG 58 (67%) 11 (58%) 33 (69%) 14 (70%)
Talent 10 (11%) 2 (11%) 7 (15%) 1 (5%)
TX2 19 (22%) 6 (32%) 8 (17%) 5 (25%)
Exposed proximal springs or barbs 29 (33%) 8 (42%) 15 (31%) 6 (30%) .65
AVR, Aortic valve replacement; CP, cerebral perfusion; CPB, cardiopulmonary bypass; DHCA, deep hypothermic circulatory arrest; NA, not applicable; SET,
stented elephant trunk; TAAA, thoracoabdominal aneurysm repair.
Values expressed as mean 6 standard deviation, median [interquartile range], or number (percent).
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10% (n ¼ 2) of patients because of symptomatic aneurysm
(n ¼ 1) or contained ruptured descending thoracic aortic
aneurysm after stage 1 repair (n ¼ 1).
All patients required median sternotomy, CPB, and
DHCA for total arch replacement. Total arch replacement
via individual aortic arch vessel reimplantation (modiﬁed
Mt. Sinai technique) was performed in 95% (n ¼ 19) of
patients; one patient (5%) underwent total arch replace-
ment at an outside hospital via the island technique. All
patients underwent staged open/endovascular repair; 40%
(n ¼ 8) underwent completion of both stages duringa single hospitalization. The LSCA was revascularized in
90% (n ¼ 18) of patients.
All 20 patients survived the stage 1 procedure and
underwent stage 2 endovascular completion. Including
both stages, two (10%) patients experienced stroke. The
ﬁrst patient experienced an embolic perioperative stroke
during total arch replacement. The second patient experi-
enced severe antibiotic-induced hemolytic anemia after
readmission within 30 days for pneumonia following
uneventful stage 2 endovascular completion. This patient
experienced a cardiac arrest secondary to profound acute
anemia resulting in anoxic brain injury and death.
Table III. Arch vessel bypass grafts
Bypass grafts
Total
(N ¼ 87)
Zone 1
(n ¼ 19)
Zone 0
(n ¼ 48)
Total arch þ SET
(n ¼ 20)
Four-vessel head graft (aorta-RSCA, RCCA, LCCA, LSCA) 1 (1%) 1 (2%)
Classic trifurcated head graft (aorta-IA, LCCA, LSCA) 15 (17%) 1 (2%) 14 (70%)
Modiﬁed trifurcated head graft (aorta-right axillary artery, RCCA, LCCA 1 (1%) 1 (2%)
Modiﬁed trifurcated head graft (aorta-RCCA, LCCA, LSCA) 2 (2%) 2 (4%)
Classic bifurcated head graft (aorta-IA, LCCA) 44 (51%) 39 (81%) 5 (25%)
Modiﬁed bifurcated head graft (aorta-IA, LSCA) 1 (2%) 1 (2%)
Aorta-IA 2 (2%) 2 (4%)
Aorta-LCCA 1 (5%) 1 (5%)
RCCA-LCCA 20 (23%) 17 (89%) 3 (6%)
RSCA-LCCA 1 (1%) 1 (5%)
LCCA-LSCAa 29 (33%) 10 (53%) 18 (38%) 1 (5%)
LCCA-left axillary artery 1 (1%) 1 (5%)
RSCA-LSCA 1 (1%) 1 (5%)
RSCA-RCCA 1 (1%) 1 (2%)
RCCA-right axillary artery 1 (1%) 1 (2%)
Left vertebral-LSCA transposition 1 (1%) 1 (2%)
Left vertebral-LCCA transposition 1 (1%) 1 (2%)
Total number of grafts 123 29 72 22
Total vessels bypassed 207 29 123 55
IA, Innominate artery; LCCA, left common carotid artery; LSCA, left subclavian artery; RCCA, right common carotid artery; RSCA, right subclavian artery;
SET, stented elephant trunk
Data expressed as number (percent).
aIncludes ﬁve patients who underwent delayed LCCA-LSCA bypass for left upper extremity ischemia (n ¼ 3), vertebrobasilar insufﬁciency (n ¼ 1), or left
upper extremity dialysis access placement (n ¼ 1).
Table IV. Thirty-day/in-hospital outcomes
Complication
Total
(N ¼ 87)
Zone 1
(n ¼ 19)
Zone 0
(n ¼ 48)
Total arch þ SET
(n ¼ 20) P
In-hospital death 5 (5.7%) 1 (5.3%) 4 (8.3%) 0 .40
Thirty-day/in-hospital death 13 (14.9%) 1 (5.3%) 10 (20.8%) 2 (10%) .21
Stroke (neurologic deﬁcit lasting >72 hours) 4 (4.6%) 0 2 (4.2%) 2 (10%) .32
Permanent paraplegia/paraparesis 1 (1.2%) 1 (5.3%) 0 0 .16
Retrograde type A dissection 3 (3.4%) 0 3 (6.3%) 0 .28
Myocardial infarction 1 (1.2%) 1 (5.3%) 0 0 .16
Acute renal failure
(creatinine >2.0 mg/dL and >2 baseline)
6 (6.9%) 0 3 (6.3%) 3 (15%) .18
New-onset dialysis 3 (3.5%) 0 2 (4.2%) 1 (5%) .64
Tracheostomy 6 (6.9%) 0 4 (8.3%) 2 (10%) .39
Length of stay, days 8 [5, 16] 4 [3, 7] 7 [5, 15] 19 [12, 30] <.0001
Primary technical success 84 (97%) 18 (95%) 46 (96%) 20 (100%) .61
SET, Stented elephant trunk.
Includes cumulative morbidity for stage 1 and stage 2 procedures for staged patients. Values expressed as median [interquartile range] or number (percent).
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stage 2 procedure. However, two (10%) patients died after
hospital discharge but within 30 days of operation, yielding
a 30-day/in-hospital mortality rate of 10%. The causes of
death were the aforementioned case of hemolytic anemia
(n ¼ 1) and pulmonary embolism (n ¼ 1).
Univariate predictors of 30-day/in-hospital mor-
tality. All variables contained within Tables I and II were
tested for univariate association with 30-day/in-hospital
mortality. Only native zone 0 proximal landing zone was
associated with 30-day/in-hospital mortality compared
with all other hybrid arch cases (odds ratio, 4.63; 95%
conﬁdence interval, 1.35-15.89; P ¼ .02). All othervariables, including age (P ¼ .61), age $75 (P ¼ .40),
EuroSCORE II (P ¼ .18), principal procedure type (P ¼
.21), dissection indication (P ¼ .24), preoperative cardiac
catheterization (P ¼ .87), and nonelective operation (P ¼
.41), were not associated with 30-day/in-hospital mortality
on univariate analysis.
Long-term follow-up
Reinterventions and graft patency. Reinterventions
and graft patency during follow-up are shown in Table V.
Over a mean follow-up of 28.5 6 22.2 months, 13% (n ¼
11) of patients required reintervention for endoleak. One
(1%) additional patient with a zone 1 hybrid arch
Table V. Reinterventions and graft patency
Variable Total (N ¼ 87) Zone 1 (n ¼ 19) Zone 0 (n ¼ 48) Total arch þ SET (n ¼ 20) P
Duration of follow-up, months 28.5 6 22.2 33.7 6 23.0 28.4 6 21.5 23.4 6 23.3 .33
Reintervention for endoleak 11 (13%) 2 (11%) 8 (17%) 1 (5%) .40
Type IA 4 (5%) 0 4 (8%) 0 .18
Type IB 0 0 0 0 1
Type II 6 (7%) 2 (11%) 4 (8%) 0 .36
Type III 1 (1%) 0 0 1 (5%) .18
Arch vessel bypass graft revision 1 (1%) 1 (5%) 0 0 .16
Patency of bypassed arch vessels 204/207 (99%) 28/29 (97%) 122/123 (99%) 54/55 (98%) 1
Aortic reintervention for new disease 5 (6%) 0 3 (6%) 2 (10%) .40
SET, Stented elephant trunk.
Values expressed as mean 6 standard deviation or number (percent).
Fig 6. Kaplan-Meier estimates of survival by procedure type. N,
Number at risk; SE, standard error; SET, stented elephant trunk.
*Time point at which SE exceeds 10%.
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thrombosis of the bypass graft noted on surveillance
imaging, and ﬁve (6%) patients required reintervention for
new aortic pathology. During follow-up, three of the 207
(1%) bypassed arch vessels were found to be occluded. Two
involved the left carotid limbs of bifurcated or trifurcated
head grafts, and one involved an occluded carotid-carotid
bypass. All three occluded grafts were identiﬁed inciden-
tally on imaging and were clinically silent.
Survival. Kaplan-Meier estimates of survival are shown
in Fig 6. Overall survival for the entire hybrid arch cohort
at 1 year, 3 years, and 5 years was 73%, 60%, and 51% and
was equivalent between procedures (P ¼ .819)
DISCUSSION
This report presents our algorithmic approach to the
use of TEVAR for aortic arch repair in high-risk patients
by way of three complementary procedures. The overall
rates of stroke (4.6%), paraplegia (1.2%), in-hospital
mortality (5.7%), and 30-day mortality (14.9%) appear
favorable and suggest that hybrid procedures are important
in the armamentarium of treatment options for arch
pathology in select patients. However, the data reveal
some important limitations to the application of hybrid
arch operations that warrant discussion.
Perioperative mortality after hybrid arch repair is
frequently reported as in-hospital mortality,10-12,20 as
opposed to the conventional 30-day/in-hospital mortality
deﬁnition used in cardiovascular surgery. In the current
study, eight patients died after hospital discharge but
within 30 days of surgery, yielding a clinically signiﬁcant
difference between in-hospital (5.7%) and 30-day/in-
hospital (14.9%) mortality. This ﬁnding confuses the
comparison of operative mortality between reports and
suggests studies that report only in-hospital mortality may
signiﬁcantly underestimate 30-day/in-hospital mortality.
Nonetheless, the procedure-speciﬁc 30-day/in-hospital
mortality rates in this study are comparable to prior reports
of zone 1 hybrid arch repair (0%-15.6%),11,12,17,18 zone
0 hybrid arch repair (8.5%-29.6%),9-12,14,17,20 stented
elephant trunk completion (4.5%-11%),1,2,6,7,13 and total
arch replacement with stented elephant trunk completion
(17%).7The observation of eight (9.2%) patient deaths shortly
after hospital discharge is concerning and requires scrutiny.
The causes of death for ﬁve of the patients are known and
appear to be related to comorbid conditions or unpredict-
able circumstances. The causes of death for the remaining
three patients are unknown. However, two of these
patients underwent zone 0 hybrid arch repair with native
ascending aorta landing zone. Given the high incidence
of retrograde type A dissection in this group (11.1%), we
speculate that early unexplained death after native zone
0 repair may be due to unrecognized or spontaneously
occurring retrograde type A dissection in some patients.
JOURNAL OF VASCULAR SURGERY
664 Andersen et al March 2013Despite acceptable procedural mortality, we posit that
patients surviving <1 year after surgery are unlikely to
derive a survival beneﬁt from the procedure and that 1-
year survival rates are a more relevant metric of success
than procedural mortality.32 In the current study, 1-year
survival was 73% and was equivalent between procedures
(zone 1, 73%; zone 0, 72%; stented elephant trunk,
74%). These 1-year survival rates after hybrid arch repair
are similar to other reports (65%-84.2%)2,6,10,11,14,15,17-20
but are lower than the 81% to 82% 1-year survival experi-
enced by all TEVAR patients in the Duke database or other
large TEVAR registries.32-34 Correspondingly, Desai et al33
found patients undergoing hybrid arch procedures to be at
greater risk of 30-day mortality (odds ratio, 2.7) and late
mortality (odds ratio, 2.1) compared with patients under-
going other TEVAR procedures. These data likely reﬂect
the increased operative complexity of hybrid arch opera-
tions and the preferential use of hybrid arch repair in
high-risk patients who are deemed unﬁt for conventional
open surgery. Regardless, patient selection for hybrid
arch repair may require further reﬁnement given that
approximately one-fourth of patients may not experience
a survival beneﬁt from the procedure using current selec-
tion criteria.
Retrograde type A dissection appears to be a frequent
and often lethal complication of hybrid arch repair.
Although retrograde type A dissection may occur after any
TEVAR procedure, the incidence appears to be especially
high after endograft placement in the ascending aorta. In
the present series, three patients experienced retrograde
type A dissection, for an overall incidence of 3.4%. However,
given that patients with artiﬁcial Dacron ascending aorta are
not at risk for this complication, the rate of retrograde type A
dissection in patients with native ascending aorta was 6.5%
(3/46). In patients with native ascending aorta who
underwent zone 0 endograft placement, the rate was
11.1% (3/27). These data appear similar to a report by
Czerny et al20 of 66 zone 0 hybrid arch repairs performed
at ﬁve institutions. Of the 66 patients, two experienced early
retrograde type A dissection, and three experienced late
retrograde type A dissection, for an overall rate of 7.6%.
However, the report includes ﬁve patients with previous
type A dissection repair and 15 patients who underwent
ascending aorta replacement at the time of arch debranch-
ing. The rate of retrograde type A dissection in patients
with native ascending aorta was likely at least 10.8%
(5/46), which is nearly identical to our study.
The causes of retrograde type A dissection in zone
0 patients suggested by Czerny et al20 include clamp injury
to the ascending aorta during performance of the proximal
debranching anastomoses, compliance mismatch between
the rigid endograft and the ascending aorta, and alterations
in blood ﬂow caused by the debranching graft itself. In
addition, our group previously found retrograde type A
dissection after TEVAR was more likely to occur in patients
treated for a dissection indication, in patients with an
ascending aorta $4 cm in diameter and in patients in
whom devices with exposed proximal barbs or springswere used.29 As a result of this prior publication and the
present ﬁndings, we now aim to replace the ascending aorta
whenever feasible in patients undergoing zone 0 hybrid
arch repair who harbor these risk factors for retrograde
type A dissection.
The high incidence of retrograde type A dissection
appears to represent a major technical limitation of the
zone 0 hybrid arch operation. Total endovascular aortic
arch repair through the use of branched endografts or
chimney grafts may lead to improved results and ultimately
replace the zone 0 hybrid arch operation if the incidence of
retrograde type A dissection is reduced.35,36 Alternatively,
retrograde type A dissection may occur uniformly when-
ever endografts are placed within the ascending aorta
despite the avoidance of clamping and arch debranching.
In this case, conventional open arch repair or prophylactic
ascending aorta replacement before endograft placement
may prove superior to all native ascending aorta–based
endovascular repair options in patients who can tolerate
the open procedures. Additional work is needed to investi-
gate this possibility.
Limitations. The present report describes a large
cohort of patients undergoing hybrid arch repair and
represents to our knowledge the largest single-institution
series of zone 0 hybrid arch repairs in the literature.
However, the study remains limited by the constraints of
sample size, which limits the comparison of ﬁndings
between procedures and precludes the use of multivariable
statistics for risk factor analysis. The operations were per-
formed by two principal cosurgeons using standardized
techniques, and results may not be generalizable to other
practitioners treating different patient populations in
different arenas.
CONCLUSIONS
Patients with transverse arch aneurysms selected for
hybrid arch repair represent a high-risk patient cohort, as
evidenced by an expected in-hospital mortality rate of
16.3% as calculated by the EuroSCORE II. Despite this
limitation, acceptable outcomes are possible when opera-
tions are tailored to patient anatomy and comorbid status.
However, 30-day and 1-year mortality remain consider-
able, and we suspect patient selection may beneﬁt from
further reﬁnement. Lastly, the native ascending aorta
appears to be a hostile location for endograft placement
and is associated with high rates of retrograde type A
dissection and 30-day/in-hospital mortality. As a result,
we recommend caution with native zone 0 stent graft
placement, and we now aim to replace the ascending aorta
when feasible in scenarios previously shown to be at high
risk for retrograde type A dissection.
The authors thank Stan Coffman for providing
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that needed a median sternotomy, in how many of those, if any,
would you put the stent graft in antegrade? What’s your preferred
approach in those cases where you have the chest open?
Dr Nicholas D. Andersen. About two-thirds of the grafts
were placed antegrade during the zone 0 repair, and the remainder
were placed retrograde. I’d have to ask Dr Hughes, who is in the
audience, to clarify how he decides to place the graft antegrade or
retrograde.
Dr Ricotta. And, I guess the follow-up question would be if
retrograde dissection was the cause of 50% of your in-hospital
deaths in that group, is one approach better than the other?
Dr Andersen. For retrograde dissection?
Dr Ricotta. Yes. Antegrade or retrograde, is it catheter
manipulation, or is it introduction of the device?
Dr Andersen. We previously performed an extensive analysis
of our retrograde dissections, which was recently published in the
Journal of Vascular Surgery, and in that study, we did not ﬁnd an
association between retrograde type A dissection and the direction
of graft deployment.
Dr G. Chad Hughes (Durham, NC). The vast majority of
the time with a zone 0 debranching procedure, we will perform
antegrade stent graft deployment through the integral antegrade
limb of the arch debranching graft we use for these procedures.
The caveat is that you should use a TAG device, as that is the
best device for antegrade deployment given that it deploys from
the middle out and seems to seal well regardless of which end is
facing in the direction of the oncoming blood ﬂow. So, if you
wanted to use one of the other devices, such as Talent, Valiant,
or TX2, which deploy from proximal to distal, you would have
to come retrograde. That’s probably the only time that we
wouldn’t go antegrade; it would be for a device reason.
Dr Kristofer Charlton-Ouw (Houston, Tex). When you have
a stented elephant trunk procedure, why debranch the arch? Also, I
noticed your stroke rate is 10%, which is more than double than if
you just ﬁxed the arch under circulatory arrest.
Dr Andersen. I think that just represents our preferred tech-
nique for total arch replacement. In general, our stroke rate from
total arch replacement appears to be equivalent to other series in
the literature. We had two strokes in the total arch stented elephant
trunk group, but only one was after total arch replacement, and one
was after stented elephant trunk completion. So, the 10% was
the combined number but for total arch alone, the stroke rate
was 5%.
Dr Charlton-Ouw. It’s still higher than if you just ﬁxed the
arch under circulatory arrest. I mean, in experienced aortic centers,
you’re looking at a stroke rate of less than 5% and a 30-day
mortality of less than 10%, even with the second-stage elephant
trunk.
Dr Hughes. I can comment here. The literature is pretty clear
that the “island technique” for total arch replacement carries
a higher risk of stroke than what we call the “modiﬁed Mount Sinai
technique,” where you individually re-implant the arch vessels into
a trifurcated graft. The reason for this appears to be that, with the
“island technique,” if there is an atherosclerotic arch, the most
severe atherosclerosis is at the origin of the arch vessels, and thisdiseased segment is left in place and sewn to the new arch graft
as an island. On the contrary, with the trifurcated graft technique,
this diseased area is removed, and the arch vessels are re-implanted
beyond their origins such that you are sewing to relatively normal
vessels. This is the reason most cardiothoracic surgeons who do
a lot of arch work have gone to this newer technique.
Dr William Jordan (Birmingham, Ala). I had one question
relative to your conclusion. You had a very remarkable 5% in-
hospital mortality but a 20% 30-day mortality. Might you consider
keeping those patients in the hospital to 30 days because there’s
some problem after they’re discharged?
Dr Andersen. I think that’s one of the most important things
that we observed in our series. We think there are probably three
factors involved. Some of it is probably due to patient selection and
patients succumbing to other comorbidities shortly after surgery. If
so, then some of these patients were probably not the best candi-
dates to start with. Second, perhaps some patients were sent home
too early or were not as healthy as we thought at the time of
discharge. Third, and perhaps most importantly, we speculate
that some of these early deaths may be due to unrecognized or
spontaneously occurring retrograde type A dissections. If so,
then that certainly represents a limitation of the zone 0 hybrid
arch repair.
Dr Joseph Schneider (Winﬁeld, Ill). Twenty-four years ago
during my fellowship, I did an ascending aorta-to-innominate
artery bypass. That patient died a few days later from an ascending
aorta dissection, and that patient didn’t have an endograft. Do you
think that your retrograde dissections are because of the endograft
or because of the clamping of the ascending aorta and that part of
the procedure?
DrAndersen.That’s a goodquestion.We have seen retrograde
type A dissections in patients with only zone 2 coverage, so we know
it can happen without clamping the ascending aorta. However, we
agree that clamp injury certainly may contribute. We also found in
our prior study that retrograde type A dissection occurred more
commonly in patients with an ascending aorta dilated to greater
than 4 centimeters, and we’ve now learned to either replace the
ascending aorta or avoid zone 0 stenting in those patients.
But I think it will be interesting, especially when branched
endografts come into play, to see whether the ascending aorta is
a safe place for an endograft in general or whether retrograde
dissection is still going to limit totally endovascular arch repairs
where the ascending aorta is not clamped or used for a debranching
anastomoses or endograft delivery.
Dr William Quinones-Baldrich (Los Angeles, Calif). I
congratulate you on a very excellent series and a very nice presen-
tation. The only retrograde dissection that we’ve had in our own
series is from tension at the heel of the conduit during antegrade
deployment of the endograft. We now make sure that the angle
at which the graft enters the arch is very shallow and it doesn’t
lift the heel of the conduit. This is best accomplished by tempo-
rarily exiting the conduit through a counterincision.
In some of the illustrations that you had on zone 0 cases, you
did not show a carotid subclavian bypass on the left, but in the last
illustrations you did. We prefer to revascularize the left subclavian
routinely because we think it provides collateral circulation while
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left carotid subclavian bypass for those patients?
Dr Andersen. Yes, that’s a good observation on the illustra-
tions. For the native zone 0 procedure, we routinely perform
a left carotid-subclavian bypass ﬁrst in order to allow full cerebral
blood ﬂow during debranching of the left carotid artery. So you’re
correct there.The second set of illustrations were depicting the debranch-
ing operation with ascending aorta and hemi-arch replacement.
In that operation, we do not routinely bypass the left subclavian
because the arch debranching is completed under deep hypo-
thermic circulatory arrest. So, that’s why you saw a difference in
the appearance of the subclavian bypass between those two
procedures.
